IND Enabling Preformulation Package (IEPP)
Home | Services & Solutions | Drug Product | Oral | Pre-formulation | IND Enabling Preformulation Package (IEPP)
IEPP is an integrated developability assessment service for new chemical entities (NCEs) to efficiently identify challenges and provide solutions earlier for increasing success rate and lower overall costs. It usually takes 8-12 weeks for IND ready formulation.
Platform Capabilities: Within 8-12 weeks, the most developable molecule with the optimal formulation strategy is ready for IND filing. Not limited to the small molecules (both conventional and high potency compound), also including formulation screening and selection for new modality, like PROTAC, peptide, oligonucleotide.
Why choose IEPP of WuXi STA?
- Parallel screening with bioavailability enhancing technologies enables fast formulation development with the most suitable technology.
- Animal PK study included ensures the optimal drug exposure in-vivo.
- Centralized facilities and single point of contact of all in-vitro, in-vivo and in-silico studies saves time and improve efficiency.
- IEPP operates in close collaboration with WuXi AppTec's premier MedChem, DMPK, Pharmacology, Toxicology and Bioanalysis facilities for comprehensive evaluation.
